• O1 Network
    • Articles
    • For Residents
    • For Medical Students
    • PORT Notes
    • MSK Medicine
    • Tumor Library
    • Cases
    • Talks
    • Images
    • Viewpoints
    • Question Bank
    • Devices
    • Residency
    • Fellowships
    • Associations
    • Companies
ORTHOPAEDICSONE ARTICLES
OrthopaedicsOne Articles
  • Articles
    • Specialty
      • Arthroscopy
      • Foot and Ankle
      • Hand and Wrist
      • Hip and Knee
      • Infection
      • Joint Reconstruction
      • Musculoskeletal Medicine
      • Pediatrics
      • Shoulder and Elbow
      • Spine
      • Sports Medicine
      • Trauma
      • Tumor
    • Regional
      • Anatomy
      • Basic Science
      • Classifications
      • Diagnostic Tests
      • Evidence-Based Orthopaedics
      • Operative Techniques
      • Pain Management
      • Physical Examination
      • Pharmacology
      • Radiology
      • Rehabilitation
      • Rheumatology
      • Surgical Approaches
    • Professional
      • Bioethics
      • Economics and Health Policy
      • Epidemiology and Biostatistics
      • History of Orthopaedics
      • Informatics
      • Medicolegal
      • Mobile and Wireless
      • Practice Management
  • Reviews
    • For Residents
    • For Medical Students
  • eBooks
    • PORT Notes
    • MSK Medicine
    • Tumor Library
  • Community
    • Cases
    • Talks
    • Images
    • Viewpoints
    • Question Bank
    • Devices
  • Pages
    • Residency
    • Fellowships
    • Associations
    • Companies
  • About O1
    • Overview
    • FAQs
    • Managing Editors
    • Editorial Board
    • Content Partners
    • Participating Groups
    • Advisory Board
    • Sponsoring Organizations
    • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Mechanisms of Osteoblastic Metastases – Role of Endothelin-1

Mohammad Khalid S., Guise Theresa A. Mechanisms of Osteoblastic Metastases: Role of Endothelin-1. Clinical Orthopaedics and Related Research. 2003;415:S67-S74. doi:10.1097/01.blo.0000093047.96273.4e.

Abstract

Certain solid tumors metastasize to bone, causing an osteoblastic response. The mechanisms by which tumor cells stimulate this new bone formation are not understood completely. We identified three breast cancer lines that cause osteoblastic metastases in female nude mice and provide evidence that tumor-produced endothelin-1 (ET-1) mediates the osteoblastic response. Tumor-conditioned media and exogenous ET-1 stimulated osteoblast proliferation and new bone formation in cultures of calvarias from mice. These effects were blocked by endothelin A (ETA) but not by ETB receptor antagonists. Mice inoculated with the ZR-75-1 breast cancer line and treated with a selective ETA receptor antagonist (ABT-627) had significantly fewer osteoblastic bone metastases and less tumor burden compared with untreated mice. In contrast, there was no effect of ABT-627 on osteolytic bone metastases caused by ET-1-negative breast cancer, MDA-MB-231. ABT-627 had no effect on cell growth in vitro or at the orthotopic site (mammary fat pad) of ZR-75-1, or MDA-MB-231 cells. Collectively, the data suggest that tumor-produced ET-1 mediates osteoblastic bone metastases by stimulating osteoblast proliferation and new bone formation. Endothelin A receptor blockade may be useful for the prevention and treatment of osteoblastic bone metastases attributable to breast or prostate cancer.

View Full-Text Article →

View on PubMed →

Last Updated on September 30, 2026

🔗 Knowledge Graph & Clinical Correlates

OrthopaedicsOne Living Semantic Network

🛠️ Operative Techniques

  • Total scapular resections with endoprosthetic reconstruction Musculoskeletal Tumor

🩺 Clinical Conditions & Indications

  • Who should undergo biopsy of a bone lesion Patient selection for a biopsy is important: It is intended to confirm the radiologic diagnosis in patients with...
  • Who should do the biopsy of a bone lesion Clinical studies undertaken by the Musculoskeletal Tumor Society have documented a high incidence of problems suffered by patients...
  • Where is the lesion Original Clinical Contribution: Authored for the OrthopaedicsOne Musculoskeletal Oncology Specialty Section. Preserved, digitized, and updated to modern evidence-based...
  • What is the lesion doing to the bone Bone tumors have a limited number of potential effects on the skeleton. The most common is to produce...

🔬 Anatomy, Pathology & Diagnostics

  • What kind of matrix is being made Generalized Bone and Joint
  • Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo Generalized Bone and Joint
  • Urokinase Plasminogen Activator System – A Multifunction Role in Tumour Progression and Metastasis Pelvis and Acetabulum
  • Tumor Classifications Hip Joint & Proximal Femur

🕸️ Semantic Relations (RDF)

ABOUT

  • Overview
  • FAQs
  • Managing Editors
  • Editorial Board
  • Content Partners
  • Participating Groups
  • Advisory Board
  • Sponsoring Organizations
  • Contact Us

ARTICLES

  • Arthroscopy
  • Foot and Ankle
  • Hand and Wrist
  • Hip and Knee
  • Infection
  • Joint Reconstruction
  • Musculoskeletal Medicine
  • Pediatrics
  • Shoulder and Elbow
  • Spine
  • Sports Medicine
  • Trauma
  • Tumor

REVIEWS

  • For Residents
  • For Medical Students

EBOOKS

  • PORT Notes
  • MSK Medicine
  • Tumor Library

COMMUNITY

  • Talks
  • Images
  • Viewpoints
  • Question Bank
  • Devices

PAGES

  • Residency
  • Fellowships
  • Associations
  • Companies
Copyright © 2012-2026 OrthopaedicsOne | Privacy Policy | Dr. Christian Veillette . Powered by: OrthoNet - Empowering the Future of Orthopaedic Care
Scroll to top Scroll to top Scroll to top